Supported by

Stents, scaffolds and DCB

Find all the latest content on stents and scaffolds published on this website.

Since 1986, when the first cardiovascular stent was implanted, the development of drug-eluting stents (DES) and the recent introduction of bioresorbable scaffolds have revolutionised interventional cardiology. Keep up-to-date with the latest research; evolving tools, devices and techniques; the role of adjunctive pharmacotherapy; advances in imaging techniques as well as the use of invasive imaging and functional assessment. Find out more…

Filtered By
Stents, scaffolds and DCB

568 results

Stent loss and coronary perforation: how to deal with

16 May 2024 – From EuroPCR 2024

This session explores the management of challenging complications during percutaneous coronary interventions, such as stent loss and coronary perforation. The presenters share case studies that demonstrate various techniques and strategies used to address these complications, including the use of CTO wires for distal wire perforation, managing...

Stent loss and coronary perforation: how to deal with

Mastering the future of PCI with drug-coated balloons

16 May 2024 – From EuroPCR 2024

Join this session dedicated to drug-coated balloons (DCB) to delve into the evolution of angioplasty with DCBs in the U.S. Learn about the established standard of care, balancing efficacy and safety in treating in-stent restenosis (ISR). Gain insights into the fundamental principles of angioplasty with DCB...

Mastering the future of PCI with drug-coated balloons

Sirolimus-coated balloon: exploring the case- and clinical-based evidences

16 May 2024 – From EuroPCR 2024

Browse this EuroPCR 2024 session to explore the safety and efficacy of sirolimus-coated balloons from pre-clinical data, review MagicTouch data from real-world populations with case-based examples, and learn about the MagicTouch sirolimus-coated balloon clinical programs. Discover insights and takeaways from the significance of the EASTBOURNE subgroups,...

Sirolimus-coated balloon: exploring the case- and clinical-based evidences

Restoring vessel physiology drives outcomes - The Bioadaptor experience

16 May 2024 – From EuroPCR 2024

Join this session to delve into the unmet needs concerning drug-eluting stents (DES), including poor long-term clinical outcomes, with up to a 50% MACE rate at 10 years, and a non-plateauing 2-3% annual event rate. Explore how DynamX Bioadaptor technology addresses these challenges by maintaining the...

Restoring vessel physiology drives outcomes - The Bioadaptor experience

PCI complications: mistakes in stent placement, stent elongation during implantation & more

16 May 2024 – From EuroPCR 2024

This session comprises selected EuroPCR 2024 Clinical Case submissions focusing on various PCI complications, including mistakes in stent placement, stent elongation during implantation, and unexpected stent behavior after post-dilatation. The cases are presented with interactive discussions to enhance understanding of these complex scenarios and their management.

PCI complications: mistakes in stent placement, stent elongation during implantation & more

REC-CAGEFREE II, NOTION-2, LANDMARK: Three major late-breaking trials presented at EuroPCR 2024

15 May 2024

The Course Directors have selected 3 major Late Breaking Trials (LBTs) that were presented for the first time during the 2024 edition of EuroPCR. These trials were selected on account of their design, outcomes and potential to influence daily clinical practice.

REC-CAGEFREE II, NOTION-2, LANDMARK: Three major late-breaking trials presented at EuroPCR 2024

Artificial intelligence-powered quantification of coronary physiology and vulnerable plaque: opportunities for novel treatment options

15 May 2024 – From EuroPCR 2024

In this session, uncover new data on Murray-law based quantitative flow ratio (muFR) assessment, providing a comprehensive understanding of PCI outcomes from a single angiographic view, explore the innovative application of artificial intelligence in identifying vulnerable plaque and assessing hemodynamic stenosis significance through the analysis of...

Artificial intelligence-powered quantification of coronary physiology and vulnerable plaque: opportunities for novel treatment options

Complex PCI in ACS patient with high bleeding risk: optimise the strategy

15 May 2024 – From EuroPCR 2024

Watch this session for insights into managing acute coronary syndrome patients with multivessel disease, updates on treatment approaches, comparing FULL RESVAC with previous trials like COMPLETE or FIRE, for example, and information on ongoing trials such as FRAMI-AMI 2 and 3. Explore the LIVE case presentation...

Complex PCI in ACS patient with high bleeding risk: optimise the strategy

The ARC consensus on DCB - evidence-based DCB technology

15 May 2024 – From EuroPCR 2024

In this replay, discover why DCBs are essential in treating de novo CAD, the importance of optimal lesion preparation for long-term success, and how future trials will focus on treatment strategies rather than device comparisons, highlighting the need for further research.

Evidence-based on DCB technology that have dictated the ARC consensus on DCB

Make your life easier with imaging during primary PCI for acute coronary syndrome

15 May 2024 – From EuroPCR 2024

This session features selected EuroPCR 2024 Clinical Case submissions highlighting the use of imaging modalities, such as optical coherence tomography (OCT) and intravascular ultrasound (IVUS), during primary percutaneous coronary interventions (PCI) for acute coronary syndrome. Experts will present and discuss challenging cases, demonstrating how the integration...

Make your life easier with imaging during primary PCI for acute coronary syndrome